Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms

INTRODUCTION: Coronavirus disease 2019 (COVID-19) and influenza share similar symptoms, which hampers diagnosis. Given that they require different containment and treatment strategies, fast and accurate distinction between the two infections is needed. This study evaluates the sensitivity and specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Jayne E., Guest, Poppy, Lawson, Vicki, Loecherbach, Julia, Lindner, Nigel, McCulloch, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510530/
https://www.ncbi.nlm.nih.gov/pubmed/36152227
http://dx.doi.org/10.1007/s40121-022-00696-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510530/
https://www.ncbi.nlm.nih.gov/pubmed/36152227
http://dx.doi.org/10.1007/s40121-022-00696-8

Ejemplares similares